AGTC Applied Genetic Technologies Corp

Applied Genetic Technologies Corp is a clinical-stage biotechnology company focused on gene therapy through a nontoxic adeno-associated virus. The company also offers products such as promoters, expression cassettes, and capsids for gene therapy.

$5.08
As of 02/26/2021     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Biotechnology
USA
USA
03/27/2014
42,657,878
7,512,348
$216,702,020
0.00%
SEC Edgar Online
10-Q
10-K
03820J100
US03820J1007
BKRVPJ9

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-14.94
3.17
88.34
-136.15%
-2,304.69%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy